July 7, 2016 / 11:17 AM / a year ago

BRIEF-Orbimed Advisors acquired 480,000 common shares of Cynapsus Therapeutics

July 7 (Reuters) - Orbimed Advisors Llc

* Acquired 480,000 common shares of cynapsus therapeutics inc

* Now collectively beneficially owns, controls and directs more than 10% of outstanding common shares of cynapsus

* Common shares were acquired at a price of us$13.00 per common share for total consideration paid of us$6.3 million Source text for Eikon: Further company coverage: )

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below